Evaluation of the Pedal-Controlled Surgistep Platform to Improve Ergonomics
A Prospective Crossover Study Evaluating the Pedal-Controlled Surgistep Platform to Improve Ergonomics in Neurosurgical Operations
1 other identifier
interventional
10
1 country
1
Brief Summary
Primary Aim: Assess improvement in ergonomics and musculoskeletal discomfort with the Surgistep compared to a standard footstool.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2025
CompletedFirst Submitted
Initial submission to the registry
August 22, 2025
CompletedFirst Posted
Study publicly available on registry
August 26, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2025
CompletedAugust 26, 2025
August 1, 2025
2 months
August 22, 2025
August 22, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Rapid Entire Body Assessment (REBA) Scale Score
The REBA (Rapid Entire Body Assessment) score, used to assess the risk of musculoskeletal disorders (MSDs) in work tasks, ranges from 1 to 15. A lower REBA score indicates a lower risk, with scores below 4 considered to have minimal risk. Higher scores indicate increased risk, with scores of 8 or more indicating a high risk that requires immediate attention and intervention
During the surgery upto 60 minutes
Rapid Upper Limb Assessment (RULA) Scale Score
The RULA (Rapid Upper Limb Assessment) scale ranges from 1 to 7, with lower scores indicating lower risk and higher scores indicating higher risk of musculoskeletal disorders.
During the surgery upto 60 minutes
Study Arms (2)
SurgiStep Platform
EXPERIMENTALThe surgeon will be performing the surgery by standing over the SurgiStep Platform. The duration of the usage depends on the length of the surgery being performed by the surgeon. Surgeons will be using this platform for 2 weeks, after which they will be operating on standard foot stool for 2 weeks.
Standard surgical practice
PLACEBO COMPARATORThe surgeon will be performing the surgery by standing over the standard of care (foot stool). The duration of the usage depends on the length of the surgery being performed by the surgeon. Surgeons use standard foot stool for 2 weeks, and switch to SurgiStep platform for 2 weeks.
Interventions
The Surgistep (pedal-controlled, adjustable platform) allows real-time height adjustment during surgery. The surgeons can adjust the height of the platform.
Foot stool is considered as the standard of care during surgery.
Eligibility Criteria
You may qualify if:
- Regularly perform neurosurgical procedures (cranial/spine)
- Willing to use both devices (multiple times each).
You may not qualify if:
- Severe MSK conditions preventing device usage
- Inability/refusal to participate in observation or surveys.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford Health Care
Palo Alto, California, 94305, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Atman Desai, MD
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
August 22, 2025
First Posted
August 26, 2025
Study Start
August 1, 2025
Primary Completion
October 1, 2025
Study Completion
November 1, 2025
Last Updated
August 26, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share